Blockade of T-type calcium channels by 6-prenylnaringenin, a hop component, alleviates neuropathic and visceral pain in mice

被引:24
|
作者
Sekiguchi, Fumiko [1 ]
Fujita, Tomoyo [1 ]
Deguchi, Takahiro [2 ]
Yamaoka, Sakura [1 ]
Tomochika, Ken [1 ]
Tsubota, Maho [1 ]
Ono, Sumire [1 ]
Horaguchi, Yamato [1 ]
Ichii, Maki [1 ]
Ichikawa, Mio [1 ]
Ueno, Yumiko [1 ]
Koike, Nene [1 ]
Tanino, Tadatoshi [3 ]
Huy Du Nguyen [4 ]
Okada, Takuya [4 ]
Nishikawa, Hiroyuki [1 ]
Yoshida, Shigeru [5 ]
Ohkubo, Tsuyako [6 ]
Toyooka, Naoki [4 ,7 ]
Murata, Kazuya [2 ]
Matsuda, Hideaki [2 ]
Kawabata, Atsufumi [1 ]
机构
[1] Kindai Univ, Lab Pharmacol & Pathophysiol, Fac Pharm, 3-4-1 Kowakae, Higashiosaka, Osaka 5778502, Japan
[2] Kindai Univ, Div Nat Drug Resources, Fac Pharm, Higashiosaka, Osaka 5778502, Japan
[3] Tokushima Bunri Univ, Fac Pharmaceut Sci, Dept Pharmaceut, Tokushima 7708514, Japan
[4] Univ Toyama, Grad Sch Innovat Life Sci, Toyama 9308555, Japan
[5] Kindai Univ, Dept Life Sci, Fac Sci & Engn, Higashiosaka, Osaka 5778502, Japan
[6] Fukuoka Nursing Coll, Fac Nursing, Div Basic Med Sci & Fundamental Nursing, Fukuoka, Fukuoka, Japan
[7] Univ Toyama, Grad Sch Sci & Engn, Toyama 9308555, Japan
关键词
T-type calcium channel; 6-Prenylnaringenin; Sophoraflavanone G; Neuropathic pain; Visceral pain; HYDROGEN-SULFIDE; MECHANICAL HYPERALGESIA; DIABETIC-NEUROPATHY; SOPHORA-FLAVESCENS; HUMULUS-LUPULUS; SENSORY NEURONS; NG108-15; CELLS; TRPA1; CHANNELS; SCIATIC-NERVE; UP-REGULATION;
D O I
10.1016/j.neuropharm.2018.06.020
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Since Ca(v)3.2 T-type Ca2+ channels (T-channels) expressed in the primary afferents and CNS contribute to intractable pain, we explored T-channel-blocking components in distinct herbal extracts using a whole-cell patch-clamp technique in HEK293 cells stably expressing Ca(v)3.2 or Ca(v)3.1, and purified and identified sophoraflavanone G (SG) as an active compound from SOPHORAE RADIX (SR). Interestingly, hop-derived SG analogues, (2S)-6-prenylnaringenin (6-PNG) and (2S)-8-PNG, but not naringenin, also blocked T-channels; IC50 (mu M) of SG, (2S)-6-PNG and (2S)-8-PNG was 0.68-0.75 for Ca(v)3.2 and 0.99-1.41 for Ca(v)3.1. (2S)-6-PNG and (2S)-8-PNG, but not SG, exhibited reversible inhibition. The racemic (2R/S)-6-PNG as well as (2S)-6-PNG potently blocked Ca(v)3.2, but exhibited minor effect on high-voltage-activated Ca2+ channels and voltage-gated Na+ channels in differentiated NG108-15 cells. In mice, the mechanical allodynia following intraplantar (i.pl.) administration of an H2S donor was abolished by oral or i.p. SR extract and by i.pl. SG, (2S)-6-PNG or (2S)-8-PNG, but not naringenin. Intraperitoneal (2R/S)-6-PNG strongly suppressed visceral pain and spinal ERK phosphorylation following intracolonic administration of an H2S donor in mice. (2R/S)-6-PNG, administered i.pl. or i.p., suppressed the neuropathic allodynia induced by partial sciatic nerve ligation or oxaliplatin, an anti-cancer agent, in mice. (2R/S)-6-PNG had little or no effect on open-field behavior, motor performance or cardiovascular function in mice, and on the contractility of isolated rat aorta. (2R/S)-6-PNG, but not SG, was detectable in the brain after their i.p. administration in mice. Our data suggest that 6-PNG, a hop component, blocks T-channels, and alleviates neuropathic and visceral pain with little side effects. (C) 2018 Elsevier Ltd. All rights reserved.
引用
收藏
页码:232 / 244
页数:13
相关论文
共 50 条
  • [21] Targeting N-type and T-type calcium channels for the treatment of pain
    McGivern, JG
    DRUG DISCOVERY TODAY, 2006, 11 (5-6) : 245 - 253
  • [22] Icariside II, a Prenyl-Flavonol, Alleviates Inflammatory and Neuropathic Pain by Inhibiting T-Type Calcium Channels and USP5-Cav3.2 Interactions
    Ali, Md Yousof
    Gadotti, Vinicius M.
    Huang, Sun
    Garcia-Caballero, Agustin
    Antunes, Flavia T. T.
    Jung, Hyun Ah
    Choi, Jae Sue
    Zamponi, Gerald W.
    ACS CHEMICAL NEUROSCIENCE, 2023, 14 (10): : 1859 - 1869
  • [24] Cav3.2 T-type calcium channels and inflammatory pain
    Kerckhove, N.
    Boudieu, L.
    Carvalho, F.
    Alloui, A.
    Uebele, V.
    Renger, J.
    Gelot, A.
    Bourinet, E.
    Mallet, C.
    Eschalier, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 27 : 117 - 117
  • [25] The Role of T-Type Calcium Channels in Peripheral and Central Pain Processing
    Todorovic, Slobodan M.
    Jevtovic-Todorovic, Vesna
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2006, 5 (06) : 639 - 653
  • [26] T-type calcium channels: An emerging therapeutic target for the treatment of pain
    Snutch, Terrance P.
    David, Laurence S.
    DRUG DEVELOPMENT RESEARCH, 2006, 67 (04) : 404 - 415
  • [27] Is there a role for T-type calcium channels in peripheral and central pain sensitization?
    Michael T. Nelson
    Slobodan M. Todorovic
    Molecular Neurobiology, 2006, 34 : 243 - 248
  • [28] Is there a role for T-type calcium channels in peripheral and central pain sensitization?
    Nelson, Michael T.
    Todorovic, Slobodan M.
    MOLECULAR NEUROBIOLOGY, 2006, 34 (03) : 243 - 248
  • [29] T-type Calcium Channels: Functional Regulation and Implication in Pain Signaling
    Sekiguchi, Fumiko
    Kawabata, Atsufumi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2013, 122 (04) : 244 - 250
  • [30] Pharmacological characterization of sophoraflavanone G and 6-prenylnaringenin, novel T-type Ca2+ channel blockers: distinct electrophysiological properties and anti-hyperalgesic activity in mice
    Ono, Sumire
    Yamaoka, Sakura
    Sekiguchi, Fumiko
    Ichii, Maki
    Fujita, Tomoyo
    Deguchi, Takahiro
    Tsubota, Maho
    Nishikawa, Hiroyuki
    Yoshida, Shigeru
    Murata, Kazuya
    Matsuda, Hideaki
    Toyooka, Naoki
    Ohkubo, Tsuyako
    Kawabata, Atsufumi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2016, 130 (03) : S146 - S146